Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new build. This change is metadata-level and does not alter the study details or other visible content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a backend update to the page. This signals an underlying update to the page template or documentation without altering visible content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small update to the page tooling or template, while the visible study information and structure remain the same.SummaryDifference0.1%

- Check60 days agoChange DetectedFooter revision label updated from v3.6.0 to v3.6.2, signaling a newer page release. This change does not modify any study content, eligibility criteria, or results.SummaryDifference0.1%

- Check67 days agoChange DetectedThere are no additions or deletions reported for this study page. The page content remains unchanged as a result.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded user-help sections: How to Read a Study Record, Common Questions, How to Join a Study, and a formatting update for Intervention/Treatment. Release notes were updated to Revision: v3.6.0.SummaryDifference0.5%

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.